Authors
1 Gynecology Department, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
2 Young Researchers and Elites Club, Faculty of Medicine, Islamic Azad University, Yazd, Iran
Abstract
No Abstract
Keywords
- Smith RA, Andrews K, Brooks D, DeSantis CE, Fedewa SA, LortetTieulent J, et al. Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2016;66(2):96-114. [DOI:10.3322/caac.21336] [PMID]
- Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, Ogilvie G, et al. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine. 2012;30 Suppl 5:F88-99. [DOI:10.1016/j.vaccine.2012.06.095] [PMID]
- Teoh DG, Marriott AE, Isaksson Vogel R, Marriott RT, Lais CW, Downs LJ, et al. Adherence to the 2012 national cervical cancer screening guidelines: a pilot study. Am J Obstet Gynecol. 2015;212(1):62 e1-9. [DOI:10.1016/j.ajog.2014.06.057] [PMID]
- Lees BF, Erickson BK, Huh WK. Cervical cancer screening: evidence behind the guidelines. Am J Obstet Gynecol. 2016;214(4):438-43. [DOI:10.1016/j.ajog.2015.10.147] [PMID]
- Aboul-Fotouh MEM, Hana IT. Clinical validation of high risk HPV DNA testing versus ThinPrep cytology for primary cervical cancer screening. Middle East Fertil Soc J. 2013;18(2):102-9. [DOI:10.1016/j.mefs.2012.12.001]
- Karimi-Zarchi M, Zanbagh L, Shafii A, Taghipour-Zahir S, Teimoori S, Yazdian-Anari P. Comparison of Pap Smear and Colposcopy in Screening for Cervical Cancer in Patients with Secondary Immunodeficiency. Electron Physician. 2015;7(7):1542-8. [DOI:10.19082/1542] [PMID]
)
